DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20183603

Evaluation of mass drug administration against lymphatic filariasis in Bidar district, Karnataka, India

Ravindranath A. Bhovi, Vijaykumar P. Mane

Abstract


Background: Lymphatic filariasis is a major public health problem in India not only because it causes considerable suffering, deformity and disability but also due to social stigma and economic loss associated with it. The Government of India in 2004 began a nationwide mass drug administration (MDA) campaign in all the known endemic districts with the aim of eliminating it as a public health problem. However, even after a decade, uncertainty prevails about the coverage and compliance to MDA. Objectives of the study were to estimate coverage and compliance to mass drug administration (MDA) in Bidar district and to identify the various reasons for non-compliance to MDA.

Methods: A cross sectional evaluation survey was conducted in the month of September 2016 in Bidar district using multi-stage cluster sampling technique. A total of 744 subjects were interviewed and information was collected in a predesigned questionnaire after taking an informed consent. Data thus obtained were entered and analyzed using Epi info software version 3.5.4.

Results: The coverage, compliance and effective compliance to MDA in Bidar district were 82.1%, 72.3% and 59.4% respectively. The most common reasons for non-compliance to MDA were fear of side reactions followed by suffering from other chronic diseases and having no faith in tablets. The most common side reactions associated with drug intake were vomiting and fever.

Conclusions: The present study demonstrates poor compliance to MDA in Bidar district despite good coverage, indicating an urgent need to revitalize the programme implementation.


Keywords


Filariasis, Compliance, Surveys and questionnaires

Full Text:

PDF

References


Lymphatic Filariasis. Available at: http://www.who. int/lymphatic_filariasis/disease/en. Accessed 14 June 2017.

Lymphatic Filariasis. WHO Global programme to eliminate Lymphatic Filariasis”. Available at: http://apps.who.int/iris/bitstream/10665/44473/1/9789241500722_eng.pdf. Accessed 29 June 2017

Park K. Park’s Text book of Preventive and Social Medicine. 23rd ed. Jabalpur: M/s Banarasidas Bhanot Publishers; 2015: 270.

Ranganath BG. Coverage survey for assessing mass drug administration against lymphatic Filariasis in Gulbarga district, Karnataka, India. J Vector Borne Dis. 2010;47:61-4.

Kalimuthu M, Sunish IP, Nagaraj J, Munirathinam A, Ashokkumar V, Arunachalam N, et al. Residual microfilaraemia in rural pockets of south India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign. J Vector Borne Dis. 2015;52:182-4.

Cantey PT, Rout J, Rao G, Williamson J, Fox LM. Increasing Compliance with Mass Drug Administration Programs for Lymphatic Filariasis in India through Education and Lymphedema Management Programs. PLoS Negl Trop Dis. 2010;4(6):e728.

Krentel A, Fischer PU, Weil GJ. A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis. PLoS Negl Trop Dis. 2013;7(11):e2447.

Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, Fischer PU, et al. Determinants of Success in National Programs to Eliminate Lymphatic Filariasis: A Perspective Identifying Essential Elements and Research Needs. Am J Trop Med Hyg. 2008;79(4):480-4.

El-Setouhy M, Elaziz KMA, Helmy H, Farid HA, Kamal HA, Ramzy RMR, et al. The Effect of Compliance on the Impact of Mass Drug Administration for Elimination of Lymphatic Filariasis in Egypt. Am J Trop Med Hyg. 2007;77(6):1069-73.

Mass Drug Administration. Available at: http://nvbdcp.gov.in/MDA.html. Accessed 29 June 2017.

Kulkarni P, Kumar R, Rajegowda RM, Channabasappa HG, Ashok NC. MDA Program against lymphatic filariasis: Are we on the path to success? Experience from Uttara Kannada District, Karnataka. Int J Med Public Health. 2014;4:243-6.

Rohith M, Angadi MM. Coverage and compliance of mass drug administration for elimination of lymphatic filariasis in endemic areas of Bidar district, Karnataka. Int J Pharm Analytic Res. 2016;5(2):276-80.

Anil NS. Assessing Coverage of Mass Drug Administration against Lymphatic Filariasis in Gulbarga District, Karnataka. Int J Med Pub Health. 2012;2(3):25-8.

Gudegowda KS, Duraisamy S, Narayanappa RR, Sobagiah RT. Evaluation Of Mass Drug Administration For Lymphatic Filariasis In Bagalkot District, Karnataka, Cross Sectional Study. Nat J Res Comm Med. 2017;6(1):71-6.

Ravish KS, Ranganath TS, Basha SR. Coverage and Compliance of Mass drug Administration for Elimination of Lymphatic Filariasis in endemic areas of Bijapur district, Karnataka. Int J Bas Med Sci. 2011;2(2):86-9.

Mishra A, Kar K, Satapathy D. Mass Drug Administration against Filariasis - A study on Coverage and compliance, in a coastal district of Odisha. J Commun Dis. 2015;47(4):13-8.

Kumar P, Prajapati P, Saxena D, Kavishwar AB, Kurian G. An Evaluation of Coverage and Compliance of Mass Drug Administration 2006 for Elimination of Lymphatic Filariasis in Endemic Areas of Gujarat. Indian J Comm Med. 2008;33:38-42.

Dharukaswami, Mallayya, Koradhanyamath, Kulkarni P, Holla R. Coverage and compliance MDA programme for lymphatic filariasis in Bidar district, Karnataka, India. Asian Pac J Trop Dis. 2012;2(4):290-2.

Ranganath TS, Reddy NR. Elimination of Lymphatic Filariasis: Mass Drug Administration In Endemic Areas of (Bidar District) Karnataka-2008. Indian J Comm Med. 2012;37(4):219–22.

Patel PK. Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts. Indian J Comm Med. 2012;37(2):101-6.

Gowda P. Post mass drug administration evaluation survey for Lymphatic Filariasis in Bidar district. Int J Med Sci Public Health. 2013;2:235-8.